Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved

December 21, 2016 8:25 AM 3 min read

20 Stocks Moving In Wednesday's Pre-Market Session

by Lisa Levin Benzinga Editor

Follow

Gainers

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Posted In:

News Movers & Shakers Pre-Market Outlook Markets Movers Biotechnology Health Care Losers Top Gainers

ACNAccenture PLC

BMYBristol-Myers Squibb Co

CALACalithera Biosciences Inc

DALDelta Air Lines Inc

INCYIncyte Corp

INOInovio Pharmaceuticals Inc

INVNAlger Russell Innovation ETF

Not Available-%

LXRXLexicon Pharmaceuticals Inc

RDHLRedhill Biopharma Ltd

WGOWinnebago Industries Inc

Merus NV (NASDAQ: MRUS) shares rose 52.3 percent to $22.85 in pre-market trading. Incyte Corporation (NASDAQ: INCY) and Merus announced a global strategic research collaboration to discover and develop bispecific antibodies.
Calithera Biosciences Inc (NASDAQ: CALA) rose 17.9 percent to $3.60 in pre-market trading. Bristol-Myers Squibb Co (NYSE: BMY) and Calithera Biosciences disclosed a clinical collaboration to evaluate Opdivo in combination with CB-839 in clear cell renal cell carcinoma.
InvenSense Inc (NYSE: INVN) shares rose 17 percent to $12.68 in pre-market trading after TDK Corp announced plans to acquire InvenSense for $13 per share in cash.
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares rose 12.1 percent to $18.30 in pre-market trading after the company disclosed that its Phase 3 trial for sotagliflozin met its primary endpoint.
Danaos Corporation (NYSE: DAC) shares rose 11.1 percent to $3.00 in pre-market trading after gaining 1.85 percent on Tuesday.
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares rose 11 percent to $7.69 in pre-market trading following Phase 1 Zika vaccine update.
Winnebago Industries, Inc. (NYSE: WGO) rose 5.9 percent to $39.40 in pre-market trading after the company reported upbeat Q1 results.
Embraer SA (ADR) (NYSE: ERJ) rose 5.2 percent to $18.67 in pre-market trading after declining 1.61 percent on Tuesday.
China Eastern Airlines Corp. Ltd. (ADR) (NYSE: CEA) rose 4.1 percent to $22.3 in pre-market trading after slipping 0.42 percent on Tuesday.
Nike Inc (NYSE: NKE) shares rose 2.3 percent to $53.00 in pre-market trading as the company posted stronger-than-expected results for its second quarter on Tuesday.

xG Technology Inc (NASDAQ: XGTI) shares fell 54.7 percent to $1.64 in pre-market trading after the company reported the pricing of its $10 million offering.
Merrimack Pharmaceuticals Inc (NASDAQ: MACK) fell 20.9 percent to $4.25 in pre-market trading after the company announced that it will stop a Phase 2 study of its treatment to fight breast cancer.
Finish Line Inc (NASDAQ: FINL) shares fell 14.8 percent to $19.60 in pre-market trading after the company reported weaker-than-expected results for its fiscal third quarter and issued a downbeat forecast.
Sigma Designs Inc (NASDAQ: SIGM) fell 12.9 percent to $5.05 in pre-market trading.
RedHill Biopharma Ltd - ADR (NASDAQ: RDHL) fell 12.1 percent to $9.50 in pre-market trading. RedHill Biopharma reported a proposed concurrent public offering and registered direct offering.
Steelcase Inc. (NYSE: SCS) shares fell 9.5 percent to $15.20 in pre-market trading after the company reported weak results for its third quarter.
Advanced Accelerator Application SA(ADR) (NASDAQ: AAAP) shares fell 8.4 percent to $24.00 in pre-market trading after the company disclosed that it has received a Complete Response Letter from the FDA for Lutathera.
Delta Air Lines, Inc. (NYSE: DAL) shares fell 3.5 percent to $49.00 in pre-market trading. Delta Air Lines and Aeroméxico agreed to establish a joint cooperation agreement.
Accenture Plc (NYSE: ACN) fell 3.3 percent to $120.00 in pre-market trading after the company issued a weak outlook for the full year.
FedEx Corporation (NYSE: FDX) fell 2.4 percent to $194.00 in pre-market trading after the company reported weaker-than-expected earnings for its second quarter on Tuesday.

ACNAccenture PLC

BMYBristol-Myers Squibb Co

CALACalithera Biosciences Inc

DALDelta Air Lines Inc

INCYIncyte Corp

INOInovio Pharmaceuticals Inc

INVNAlger Russell Innovation ETF

Not Available-%

LXRXLexicon Pharmaceuticals Inc

RDHLRedhill Biopharma Ltd

WGOWinnebago Industries Inc

Comments

Loading...